Inmune Bio, Inc. Quarterly Common Stock, Shares, Issued from Q4 2017 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Inmune Bio, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2017 to Q3 2024.
  • Inmune Bio, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 22.2M shares, a 23.6% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 22.2M +4.23M +23.6% Sep 30, 2024 10-Q 2024-10-31
Q2 2024 19.7M +1.76M +9.81% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 18M +4.78K +0.03% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 18M +4.78K +0.03% Dec 31, 2023 10-Q 2024-10-31
Q3 2023 17.9M 0 0% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 17.9M 0 0% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 17.9M 0 0% Mar 31, 2023 10-Q 2023-05-03
Q4 2022 17.9M +103K +0.58% Dec 31, 2022 10-K 2024-03-28
Q3 2022 17.9M +103K +0.58% Sep 30, 2022 10-Q 2022-11-02
Q2 2022 17.9M +2.82M +18.7% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 17.9M +3.01M +20.2% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 17.8M +4.36M +32.4% Dec 31, 2021 10-K 2023-03-02
Q3 2021 17.8M +4.4M +32.7% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 15.1M +4.23M +38.8% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 14.9M +4.19M +38.9% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 13.5M +2.71M +25.2% Dec 31, 2020 10-K 2022-03-03
Q3 2020 13.4M +2.69M +25% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 10.9M +135K +1.26% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 10.7M +1.01M +10.3% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 10.8M +2.05M +23.5% Dec 31, 2019 10-K 2021-03-04
Q3 2019 10.8M Sep 30, 2019 10-Q 2019-11-08
Q2 2019 10.8M Jun 30, 2019 10-Q 2019-08-09
Q1 2019 9.74M Mar 31, 2019 10-Q 2019-05-15
Q4 2018 8.72M +400K +4.81% Dec 31, 2018 10-K 2020-03-11
Q4 2017 8.32M Dec 31, 2017 10-K 2019-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.